Isotretinoin Therapeutic Equivalence and iPLEDGE® REMS Documentation Alert
According to the FDA labeling, isotretinoin capsules are indicated for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of 5 mm or greater.


